Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19

Netana H Markovitz; Elisabeth Pedersen; Dana L Sachs; Scott C Bresler

doi:10.1016/j.jdcr.2022.07.007

Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19

JAAD Case Rep. 2022 Sep:27:156-158. doi: 10.1016/j.jdcr.2022.07.007. Epub 2022 Jul 12.

Authors

Netana H Markovitz¹, Elisabeth Pedersen², Dana L Sachs², Scott C Bresler^{2

3}

Affiliations

¹ University of Michigan Medical School, Ann Arbor, Michigan.
² Michigan Medicine Department of Dermatology, Ann Arbor, Michigan.
³ Michigan Medicine Department of Pathology, Ann Arbor, Michigan.

No abstract available

Keywords: COVID-19 antiviral; FDE, fixed drug eruption; REGN-COV2; REGN-COV2, casirivimab/imdevimab; casirivimab; drug eruption; drug reaction; imdevimab; lichenoid reaction.

Publication types

Case Reports